Global and China Viral Vector Development Service Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Viral Vector Development Service Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Retroviral Vectors
  • 1.2.3 Lentiviral Vectors
  • 1.2.4 Adenoviral Vectors
  • 1.2.5 Adeno-associated Viral Vectors
  • 1.2.6 Others Viral Vectors
• 1.3 Market by Application
  • 1.3.1 Global Viral Vector Development Service Market Share by Application: 2020 VS 2026
  • 1.3.2 Pharmaceutical Manufacturers
  • 1.3.3 Biotechnology Companies
  • 1.3.4 Research Institutes
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Viral Vector Development Service Market Perspective (2015-2026)
• 2.2 Global Viral Vector Development Service Growth Trends by Regions
  • 2.2.1 Viral Vector Development Service Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Viral Vector Development Service Historic Market Share by Regions (2015-2020)
  • 2.2.3 Viral Vector Development Service Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Viral Vector Development Service Players by Market Size
  • 3.1.1 Global Top Viral Vector Development Service Players by Revenue (2015-2020)
  • 3.1.2 Global Viral Vector Development Service Revenue Market Share by Players (2015-2020)
• 3.2 Global Viral Vector Development Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Viral Vector Development Service Revenue
• 3.4 Global Viral Vector Development Service Market Concentration Ratio
  • 3.4.1 Global Viral Vector Development Service Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Development Service Revenue in 2019
• 3.5 Key Players Viral Vector Development Service Area Served
• 3.6 Key Players Viral Vector Development Service Product Solution and Service
• 3.7 Date of Enter into Viral Vector Development Service Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Vector Development Service Breakdown Data by Type (2015-2026)

• 4.1 Global Viral Vector Development Service Historic Market Size by Type (2015-2020)
• 4.2 Global Viral Vector Development Service Forecasted Market Size by Type (2021-2026)

5 Viral Vector Development Service Breakdown Data by Application (2015-2026)

• 5.1 Global Viral Vector Development Service Historic Market Size by Application (2015-2020)
• 5.2 Global Viral Vector Development Service Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Viral Vector Development Service Market Size (2015-2026)
• 6.2 North America Viral Vector Development Service Market Size by Type (2015-2020)
• 6.3 North America Viral Vector Development Service Market Size by Application (2015-2020)
• 6.4 North America Viral Vector Development Service Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Viral Vector Development Service Market Size (2015-2026)
• 7.2 Europe Viral Vector Development Service Market Size by Type (2015-2020)
• 7.3 Europe Viral Vector Development Service Market Size by Application (2015-2020)
• 7.4 Europe Viral Vector Development Service Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Viral Vector Development Service Market Size (2015-2026)
• 8.2 China Viral Vector Development Service Market Size by Type (2015-2020)
• 8.3 China Viral Vector Development Service Market Size by Application (2015-2020)
• 8.4 China Viral Vector Development Service Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Viral Vector Development Service Market Size (2015-2026)
• 9.2 Japan Viral Vector Development Service Market Size by Type (2015-2020)
• 9.3 Japan Viral Vector Development Service Market Size by Application (2015-2020)
• 9.4 Japan Viral Vector Development Service Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Viral Vector Development Service Market Size (2015-2026)
• 10.2 Southeast Asia Viral Vector Development Service Market Size by Type (2015-2020)
• 10.3 Southeast Asia Viral Vector Development Service Market Size by Application (2015-2020)
• 10.4 Southeast Asia Viral Vector Development Service Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 UJIFILM Diosynth Biotechnologies
  • 11.1.1 UJIFILM Diosynth Biotechnologies Company Details
  • 11.1.2 UJIFILM Diosynth Biotechnologies Business Overview
  • 11.1.3 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Introduction
  • 11.1.4 UJIFILM Diosynth Biotechnologies Revenue in Viral Vector Development Service Business (2015-2020))
  • 11.1.5 UJIFILM Diosynth Biotechnologies Recent Development
• 11.2 Sanofi
  • 11.2.1 Sanofi Company Details
  • 11.2.2 Sanofi Business Overview
  • 11.2.3 Sanofi Viral Vector Development Service Introduction
  • 11.2.4 Sanofi Revenue in Viral Vector Development Service Business (2015-2020)
  • 11.2.5 Sanofi Recent Development
• 11.3 Spark Therapeutics
  • 11.3.1 Spark Therapeutics Company Details
  • 11.3.2 Spark Therapeutics Business Overview
  • 11.3.3 Spark Therapeutics Viral Vector Development Service Introduction
  • 11.3.4 Spark Therapeutics Revenue in Viral Vector Development Service Business (2015-2020)
  • 11.3.5 Spark Therapeutics Recent Development
• 11.4 UniQure
  • 11.4.1 UniQure Company Details
  • 11.4.2 UniQure Business Overview
  • 11.4.3 UniQure Viral Vector Development Service Introduction
  • 11.4.4 UniQure Revenue in Viral Vector Development Service Business (2015-2020)
  • 11.4.5 UniQure Recent Development
• 11.5 MassBiologics
  • 11.5.1 MassBiologics Company Details
  • 11.5.2 MassBiologics Business Overview
  • 11.5.3 MassBiologics Viral Vector Development Service Introduction
  • 11.5.4 MassBiologics Revenue in Viral Vector Development Service Business (2015-2020)
  • 11.5.5 MassBiologics Recent Development
• 11.6 FinVector
  • 11.6.1 FinVector Company Details
  • 11.6.2 FinVector Business Overview
  • 11.6.3 FinVector Viral Vector Development Service Introduction
  • 11.6.4 FinVector Revenue in Viral Vector Development Service Business (2015-2020)
  • 11.6.5 FinVector Recent Development
• 11.7 Thermo Fisher Scientific (Brammer Bio)
  • 11.7.1 Thermo Fisher Scientific (Brammer Bio) Company Details
  • 11.7.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
  • 11.7.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Introduction
  • 11.7.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Development Service Business (2015-2020)
  • 11.7.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
• 11.8 Cell and Gene Therapy Catapult
  • 11.8.1 Cell and Gene Therapy Catapult Company Details
  • 11.8.2 Cell and Gene Therapy Catapult Business Overview
  • 11.8.3 Cell and Gene Therapy Catapult Viral Vector Development Service Introduction
  • 11.8.4 Cell and Gene Therapy Catapult Revenue in Viral Vector Development Service Business (2015-2020)
  • 11.8.5 Cell and Gene Therapy Catapult Recent Development
• 11.9 Cobra Biologics
  • 11.9.1 Cobra Biologics Company Details
  • 11.9.2 Cobra Biologics Business Overview
  • 11.9.3 Cobra Biologics Viral Vector Development Service Introduction
  • 11.9.4 Cobra Biologics Revenue in Viral Vector Development Service Business (2015-2020)
  • 11.9.5 Cobra Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer